Physician profile
James Ehrlich
NPI 1730246232
$2,695.40
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,672 · 2022: $1,023.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $676.12 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $430.60 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $213.45 | 2021-2022 | |
| Pfizer INC. | $198.88 | 2021-2022 | |
| Celgene Corporation | $182.83 | 2021-2022 | |
| Janssen Biotech, INC. | $139.00 | 2021-2022 | |
| Braintree Laboratories, INC. | $135.26 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $114.70 | 2021 | |
| Ardelyx, INC. | $81.45 | 2022 | |
| Nestle Healthcare Nutrition INC. | $79.90 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $75.22 | 2021 | |
| Evoke Pharma, INC. | $71.52 | 2021-2022 | |
| Alfasigma USA, INC. | $49.90 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $46.26 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $35.11 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $34.71 | 2021 | |
| Redhill Biopharma INC. | $27.92 | 2021 | |
| Gilead Sciences, INC. | $26.14 | 2021 | |
| Intra-Sana Laboratories | $21.96 | 2022 | |
| Ferring Pharmaceuticals INC. | $20.89 | 2022 | |
| Genzyme Corporation | $17.06 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $16.52 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ehrlich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.